Bartl J - Search Results

1

Different effects of soluble and aggregated amyloid β42 on gene/protein expression and enzyme activity involved in insulin and APP pathways.

Bartl J, Meyer A, Brendler S, Riederer P, Grünblatt E. Bartl J, et al. J Neural Transm (Vienna). 2013 Jan;120(1):113-20. doi: 10.1007/s00702-012-0852-5. Epub 2012 Jul 11. J Neural Transm (Vienna). 2013. PMID: 22782687

2

The link between iron, metabolic syndrome, and Alzheimer's disease.

Grünblatt E, Bartl J, Riederer P. Grünblatt E, et al. Among authors: bartl j. J Neural Transm (Vienna). 2011 Mar;118(3):371-9. doi: 10.1007/s00702-010-0426-3. Epub 2010 Jun 17. J Neural Transm (Vienna). 2011. PMID: 20556444 Review.

3

Disorder-specific effects of polymorphisms at opposing ends of the Insulin Degrading Enzyme gene.

Bartl J, Scholz CJ, Hinterberger M, Jungwirth S, Wichart I, Rainer MK, Kneitz S, Danielczyk W, Tragl KH, Fischer P, Riederer P, Grünblatt E. Bartl J, et al. BMC Med Genet. 2011 Nov 22;12:151. doi: 10.1186/1471-2350-12-151. BMC Med Genet. 2011. PMID: 22107728 Free PMC article.

4

Chronic monoamine oxidase-B inhibitor treatment blocks monoamine oxidase-A enzyme activity.

Bartl J, Müller T, Grünblatt E, Gerlach M, Riederer P. Bartl J, et al. J Neural Transm (Vienna). 2014 Apr;121(4):379-83. doi: 10.1007/s00702-013-1120-z. Epub 2013 Nov 23. J Neural Transm (Vienna). 2014. PMID: 24272680

5

Comparison analysis of gene expression patterns between sporadic Alzheimer's and Parkinson's disease.

Grünblatt E, Zander N, Bartl J, Jie L, Monoranu CM, Arzberger T, Ravid R, Roggendorf W, Gerlach M, Riederer P. Grünblatt E, et al. Among authors: bartl j. J Alzheimers Dis. 2007 Dec;12(4):291-311. doi: 10.3233/jad-2007-12402. J Alzheimers Dis. 2007. PMID: 18198416

6

Gene expression as peripheral biomarkers for sporadic Alzheimer's disease.

Grünblatt E, Bartl J, Zehetmayer S, Ringel TM, Bauer P, Riederer P, Jacob CP. Grünblatt E, et al. Among authors: bartl j. J Alzheimers Dis. 2009;16(3):627-34. doi: 10.3233/JAD-2009-0996. J Alzheimers Dis. 2009. PMID: 19276557

7

Diabetes type II: a risk factor for depression-Parkinson-Alzheimer?

Riederer P, Bartl J, Laux G, Grünblatt E. Riederer P, et al. Among authors: bartl j. Neurotox Res. 2011 Feb;19(2):253-65. doi: 10.1007/s12640-010-9203-1. Epub 2010 Jun 15. Neurotox Res. 2011. PMID: 20552313 Review.

8

Effects of methylphenidate: the cellular point of view.

Bartl J, Link P, Schlosser C, Gerlach M, Schmitt A, Walitza S, Riederer P, Grünblatt E. Bartl J, et al. Atten Defic Hyperact Disord. 2010 Dec;2(4):225-32. doi: 10.1007/s12402-010-0039-6. Epub 2010 Nov 10. Atten Defic Hyperact Disord. 2010. PMID: 21432609

9

Alzheimer's disease and type 2 diabetes: two diseases, one common link?

Bartl J, Monoranu CM, Wagner AK, Kolter J, Riederer P, Grünblatt E. Bartl J, et al. World J Biol Psychiatry. 2013 Apr;14(3):233-40. doi: 10.3109/15622975.2011.650204. Epub 2012 Feb 14. World J Biol Psychiatry. 2013. PMID: 22332892 Free article.

10

In vitro study methodologies to investigate genetic aspects and effects of drugs used in attention-deficit hyperactivity disorder.

Grünblatt E, Bartl J, Marinova Z, Walitza S. Grünblatt E, et al. Among authors: bartl j. J Neural Transm (Vienna). 2013 Jan;120(1):131-9. doi: 10.1007/s00702-012-0869-9. Epub 2012 Jul 26. J Neural Transm (Vienna). 2013. PMID: 22833045 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

66 results

Search Page

Filters